Picture of 23andMe Holding Co. logo

ME 23andMe Holding Co. Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual income statement for 23andMe Holding Co., fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue305244272299220
Cost of Revenue
Gross Profit13711713313499.4
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses564429526624901
Operating Profit-258-185-254-324-681
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-251-184-221-314-667
Provision for Income Taxes
Net Income After Taxes-251-184-217-312-667
Net Income Before Extraordinary Items
Net Income-251-184-217-312-667
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-251-184-217-312-667
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-5.34-4.21-0.602-0.676-0.912